(S)-Tedizolid - CAS 1431699-67-0
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
(S)-Tedizolid
Catalog Number:
1431699-67-0
Synonyms:
(S)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one
CAS Number:
1431699-67-0
Description:
Antibacterial oxazolidinone against gram-positive species
Molecular Weight:
370.34
Molecular Formula:
C17H15FN6O3
COA:
Inquire
MSDS:
Inquire
Targets:
Antibacterial
Chemical Structure
CAS 1431699-67-0 (S)-Tedizolid

Related Antibacterial Products


CAS 1405-20-5 Polymyxin B sulfate

Polymyxin B sulfate
(CAS: 1405-20-5)

Polymyxin B sulfate is obtained from Bacillus polymyxa and related species as a mixture of polymyxins B1 and B2. They are basic polypeptides of about eight amin...

CAS 191114-48-4 Telithromycin

Telithromycin
(CAS: 191114-48-4)

Telithromycin is a semi-synthetic erythromycin derivative. It is created by substituting a ketogroup for the cladinose sugar and adding a carbamate ring in the ...

CAS 68-41-7 D-Cycloserine

D-Cycloserine
(CAS: 68-41-7)

D-Cycloserine is an analog of the amino acid D-alanine.it Inhibits cell wall biosynthesis (D-Ala peptide bond formation) and Also prevents conversion of D-Ala t...

CAS 5321-32-4 Hetacillin potassium

Hetacillin potassium
(CAS: 5321-32-4)

Hetacillin potassium is a penicillin beta-lactam antibiotic reatment for use against a wide range of common Gram-positive and Gram-negative bacteria.

CAS 869884-78-6 Radezolid

Radezolid
(CAS: 869884-78-6)

Radezolid is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. It ha...

CAS 14222-60-7 Prothionamide

Prothionamide
(CAS: 14222-60-7)

An anti-tuberculosis agent. It has also been used to treat Leprosy. Antibacterial (tuberculostatic).

CAS 845533-86-0 Bedaquiline fumarate

Bedaquiline fumarate
(CAS: 845533-86-0)

Bedaquiline fumarate is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective aga...

CAS 1431699-67-0 (S)-Tedizolid

(S)-Tedizolid
(CAS: 1431699-67-0)

Antibacterial oxazolidinone against gram-positive species

CAS 843663-66-1 Bedaquiline

Bedaquiline
(CAS: 843663-66-1)

TMC207 is a first-in-class diarylquinoline compound with a novel mechanism of action, the inhibition of bacterial ATP synthase, and potent activity against drug...

CAS 37661-08-8 Bacampicillin Hydrochloride

Bacampicillin Hydrochloride
(CAS: 37661-08-8)

Bacampicillin is a prodrug of ampicillin, a broad-spectrum aminopenicillin antibiotic with bactericidal activity.

CAS 78439-06-2 Ceftazidime Pentahydrate

Ceftazidime Pentahydrate
(CAS: 78439-06-2)

Ceftazidime is an antibiotic useful for the treatment of bacterial infections. It is can be used for joint infections, meningitis, pneumonia, sepsis, urinary tr...

CAS 68401-82-1 Ceftizoxime sodium

Ceftizoxime sodium
(CAS: 68401-82-1)

A semisynthetic cephalosporin antibiotic for the treatment of infections due to susceptible strains of microorganisms.

CAS 53994-73-3 Cefaclor

Cefaclor
(CAS: 53994-73-3)

Cefaclor is a second-generation cephalosporin antibiotic used to treat some infections caused by bacteria such as pneumonia

CAS 113617-63-3 Orbifloxacin

Orbifloxacin
(CAS: 113617-63-3)

Orbifloxacin is a third generation of fluoroquinolone that exhibits increased antibacterial activity against the Enterobacteriaceae, gram-negative and gram-posi...

CAS 140-64-7 Pentamidine isethionate

Pentamidine isethionate
(CAS: 140-64-7)

The diisethionate salt form of Pentamidine, an amidine derivative, has been found to have antiprotozoal and antifungal effect and could be commonly used against...

CAS 5490-27-7 Dihydrostreptomycin sesquisulfate

Dihydrostreptomycin sesquisulfate
(CAS: 5490-27-7)

Dihydrostreptomycin sesquisulfate is a derivative of Streptomycin used to treat bacterial diseases in cattle, pigs and sheep.

CAS 1476-53-5 Novobiocin Sodium

Novobiocin Sodium
(CAS: 1476-53-5)

Novobiocin Sodium is a very potent bacterial DNA gyrase and human organic anion transporters with Ki of 14.87 ± 0.40 μM for hOAT1, 4.77 ± 1.12 μM for hOAT3 and ...

CAS 16773-42-5 Ornidazole

Ornidazole
(CAS: 16773-42-5)

Ornidazole is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria.

CAS 165800-03-3 Linezolid

Linezolid
(CAS: 165800-03-3)

Linezolid inhibits initiation complex formation with either the 30S or the 70S ribosomal subunits from Escherichia coli.

CAS 98079-51-7 Lomefloxacin

Lomefloxacin
(CAS: 98079-51-7)

Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms, which is commonly used to ...

Reference Reading


1.Stability of Crushed Tedizolid Phosphate Tablets for Nasogastric Tube Administration.
Kennedy G1, Osborn J2, Flanagan S3, Alsayed N4, Bertolami S5. Drugs R D. 2015 Dec;15(4):329-33. doi: 10.1007/s40268-015-0108-6.
Tedizolid phosphate is approved for the treatment of acute bacterial skin and skin structure infections. To determine whether the expected dose of tedizolid phosphate can be delivered via nasogastric tube in patients who have difficulty swallowing and in whom venous access is not suitable, this in vitro study evaluated the recovery of tedizolid phosphate 200-mg tablets after crushing, dispersion in water, and passage through a nasogastric tube. To analyze the chemical stability of the crushed tablet dispersed in water, the aqueous preparation was assayed initially after dispersion and again after 4 h at room temperature. Recovery of tedizolid phosphate after the crushed tablets were dispersed in water and passed through nasogastric tubes ranged from 92.5 to 97.1 %, which is within the specified acceptance criteria of 90 to 110 %. There was no significant change in recovery values after 4 h of storage at room temperature (93.9 % initially and 94.
2.In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH1, Huang YT2, Liao CH2, Sheng WH3, Hsueh PR4. Antimicrob Agents Chemother. 2015 Oct;59(10):6262-5. doi: 10.1128/AAC.00390-15. Epub 2015 Jul 27.
Tedizolid is a novel, expanded-spectrum oxazolidinone with potent activity against a wide range of Gram-positive pathogens. A total of 425 isolates of Gram-positive bacteria were obtained consecutively from patients with acute bacterial skin and skin structure infections (ABSSSIs) or pneumonia. These isolates included methicillin-susceptible Staphylococcus aureus (MSSA) (n = 100), methicillin-resistant Staphylococcus aureus (MRSA) (n = 100), Streptococcus pyogenes (n = 50), Streptococcus agalactiae (n = 50), Streptococcus anginosus group (n = 75), Enterococcus faecalis (n = 50), and vancomycin-resistant enterococci (VRE) (Enterococcus faecium) (n = 50). The MICs of tedizolid and linezolid were determined by the agar dilution method. Tedizolid exhibited better in vitro activities than linezolid against MSSA (MIC90s, 0.5 versus 2 μg/ml), MRSA (MIC90s, 0.5 versus 2 μg/ml), S. pyogenes (MIC90s, 0.5 versus 2 μg/ml), S. agalactiae (MIC90s, 0.5 versus 2 μg/ml), Streptococcus anginosus group (MIC90s, 0.
3.In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries.
Baek JY1, Kang CI2, Kim SH3, Ko KS4, Chung DR3, Peck KR5, Hsueh PR6, Thamlikitkul V7, So TM8, Lee NY9, Song JH3; ANSORP Study Group. Diagn Microbiol Infect Dis. 2016 Mar 2. pii: S0732-8893(16)30038-4. doi: 10.1016/j.diagmicrobio.2016.02.022. [Epub ahead of print]
Tedizolid phosphate is a second-generation oxazolidinone prodrug that is potential activity against a wide range of Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, penicillin-resistant streptococci, and vancomycin-resistant enterococci. The in vitro activity of tedizolid and other comparator agents against multidrug-resistant (MDR) pneumococci from various Asian countries were evaluated. Of the S. pneumoniae clinical pneumonia isolates collected during 2008 and 2009 from 8 Asian countries (Korea, Taiwan, Thailand, Hong Kong, Vietnam, Malaysia, Philippines, and Sri Lanka), 104 isolates of MDR pneumococci were included in this study. Antimicrobial susceptibility testing for 18 antimicrobial agents was performed by broth microdilution method. Tedizolid was highly active against pneumococci. All isolates tested were inhibited at a tedizolid minimum inhibitory concentration (MIC) value of ≤0.25μg/ml (ranged from ≤0.
4.Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE1, Smith JR1, Raut A1, Rybak MJ2. J Antimicrob Chemother. 2016 Jan;71(1):152-5. doi: 10.1093/jac/dkv302. Epub 2015 Oct 16.
OBJECTIVES: Tedizolid displays potent activity against Gram-positive pathogens. In vitro studies against clinical isolates of Staphylococcus aureus and enterococci demonstrated improved tedizolid activity over linezolid. However, this is not well-characterized against a large collection of resistant isolates, including vancomycin-intermediate S. aureus (VISA), heterogeneous VISA (hVISA), daptomycin-non-susceptible (DNS) S. aureus, linezolid-resistant (LR) S. aureus and VRE. Therefore, our objective was to determine tedizolid activity versus other agents, against MRSA and VRE with various resistance phenotypes.